1-8 of 8
Jørn Starklint
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Analysis of the Daliah Trial: A Randomized Phase III Trial of Interferon-α Versus Hydroxyurea in Patients with MPN

Trine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Bjerrum, Mette Brabrand, Sarah Friis Christensen, Christina Schjellerup Eickhardt-Dalbøge, Christina Ellervik, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben A. Kruse, Morten Kranker Larsen, Torben Mourits-Andersen, Sören Möller, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Anders Lindholm Sørensen, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas S. Larsen, Hans C. Hasselbalch
Journal: Blood
Blood (2023) 142 (Supplement 1): 746.
https://doi.org/10.1182/blood-2023-173127
Published: 2023
Journal Articles

Differences in Overall Survival for Non-Western Immigrant Patients Compared to Danish-Born Patients with Diffuse Large B-Cell Lymphoma

Mikkel Runason Simonsen, Lasse Hjort Jakobsen, Marianne Tang Severinsen, Henrik Frederiksen, Carsten Utoft Niemann, Judit Mészáros Joergensen, Michael Roost Clausen, Jørn Starklint, Søren Paaske Johnsen, Tarec Christoffer El-galaly, Joachim Baech
Journal: Blood
Blood (2023) 142 (Supplement 1): 6257.
https://doi.org/10.1182/blood-2023-179786
Published: 2023
Journal Articles

Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

Trine A. Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Weis Bjerrum, Mette Brabrand, Sarah F. Christensen, Christina Schjellerup S. Eickhardt-Dalbøge, Christina Ellervik, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben A. Kruse, Morten Kranker Larsen, Torben Mourits-Andersen, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Anders Lindholm Sørensen, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas S. Larsen, Hans Carl Hasselbalch
Journal: Blood
Blood (2022) 140 (Supplement 1): 1794–1796.
https://doi.org/10.1182/blood-2022-156445
Published: 2022
Journal Articles

Labor Market Attachment in Patients with Myeloproliferative Neoplasms: A Nationwide Matched Cohort Study

Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjærsgaard, Anna Stenling, Björn Paulsson, Christen Lykkegaard Andersen, Christian Fynbo Christiansen, Jesper Stentoft, Jørn Starklint, Marianne Tang Severinsen, Mette Borg Clausen, Morten Hagemann Hilsøe, Henrik Frederiksen, Hans C. Hasselbalch, Marie Bak, Ellen Margrethe Mikkelsen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3627.
https://doi.org/10.1182/blood-2021-144587
Published: 2021
Journal Articles

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Trine Alma Knudsen, MD, Dennis Lund Hansen, MD, Lukas Frans Ocias, MD, Ole Weis Bjerrum, MD DMSc, Mette Brabrand, Daniel El Fassi, MD PhD, Mikael Frederiksen, MD, Lasse Kjær, PhD, Thomas Kielsgaard Kristensen, MSc, PhD, Torben A Kruse, Torben Mourits-Andersen, MD, Peter Møller, MD, Ulrik Malthe Overgaard, MD, Marianne Tang Severinsen, MD PhD, Vibe Skov, PhD, Jesper Stentoft, Professor, dr.MD, Jørn Starklint, MD, Karin de Stricker, MSc, PhD, Mads Thomassen, PhD, Thomas Stauffer Larsen, MD PhD, Hans Carl Hasselbalch, Professor, dr.MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 580.
https://doi.org/10.1182/blood-2018-99-111255
Published: 2018
Journal Articles

Gender-Based Differences in Efficacy of Immuno-Chemotherapy for Diffuse Large B-Cell Lymphoma Revisited: A Danish Population-Based Study

Mette Dahl Bendtsen, MSc, Lasse Hjort Jakobsen, MSc, Judit Mészáros Jørgensen, Hans Erik Johnsen, MD Professor, Pär Lars Josefsson, MD, Christian Bjørn Poulsen, Jørn Starklint, MD, Gabriela Felicia Stein, MD, Per Trøllund Pedersen, MD, Jacob Haaber Christensen, MD PhD, Martin Bøgsted, Professor, Peter de Nully Brown, MD PhD, Tarec Christoffer El-Galaly, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1561.
https://doi.org/10.1182/blood.V130.Suppl_1.1561.1561
Published: 2017
Journal Articles

Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma

Adam Vilmar, PhD MD, Bente Arboe, Par Josefsson, MD PhD, Christian Poulsen, Jacob Haaber Christensen, Judit Jørgensen, MD PhD, Paw Jensen, Jørn Starklint, Per Troellund Pedersen, Michael Pedersen, Peter de Nully Brown, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1781.
https://doi.org/10.1182/blood.V128.22.1781.1781
Published: 2016
Journal Articles

No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms - a Prospective Study

Lukas Frans Ocias, Dennis Lund Hansen, Thomas Kielsgaard Kristensen, Karin de Stricker, Daniel El Fassi, MD PhD, Jesper Stentoft, Jørn Starklint, Mikael Frederiksen, Marianne Tang Severinsen, Ole Weis Bjerrum, MD DMSc, Peter Møller, Torben Mourits-Andersen, MD, Ulrik Malthe Overgaard, Hans Carl Hasselbalch, MD Professor, DMSc, Klaus Bendtzen, Thomas Stauffer Larsen, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5177.
https://doi.org/10.1182/blood.V126.23.5177.5177
Published: 2015